Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells

Cytokine

Volumn 11, Issue 4, 1999, Pages 267-273

  Martín, Julio ^a   Quiroga, Juan Antonio ^a   Navas, Sonia ^a   Pardo, Margarita ^a   Carreño, Vicente ^a,b  

^a Hospital Pardo de Aravaca   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Biologic response modifiers; Hepatitis C virus; Non specific cytokine responses; PBMC; Th1 and Th2 patterns

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; HEPATITIS C ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

HEPATITIS C VIRUS;

EID: 0033119063     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0427     Document Type: Article

References (47)

1. Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76:241-251.
2. Gutterman JU (1994) Cytokine therapeutics: Lessons from interferon alpha. Proc Natl Acad Sci USA 91:1198-1205.
3. Romagnani S, Parronchi P, D'Elios MM, Romagnani P, Annunziato F, Piccinni MP, Manetti R, Sampognaro S, Mavilia C, De Carli M, Maggi E, Del Prete GF (1997) An update on human Th1 and Th2 cells. Int Arch Allergy Immunol 113:153-156.
4. Quiroga JA, Martín J, Pardo M, Carreño V (1994) Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to alpha-interferon. Dig Dis Sci 39:2485-2496.
5. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB (1995) Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 95:2067-2075.
6. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U (1996) T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 24:790-795.
7. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339-3344.
8. Shirai M, Akatsuka T, Pendleton CD, Houghten R, Wychowski C, Mihalik K, Feinstone S, Berzofsky JA (1992) Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol 66:4098-4106.
9. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, Shuster JR, Kuo G, Bonino F, Houghton M, Abrignani S (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580-587.
10. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD (1993) Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522-7532.
11. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, Bonino F, Abrignani S (1993) Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178:17-25.
12. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F (1994) T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286-295.
13. Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton CD, Feinstone SM (1994) An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 68:3334-3342.
14. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521-530.
15. Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, Riethmuller G, Pape GR (1995) Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21:632-638.
16. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
17. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765.
18. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV (1996) Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432-1440.
19. Unutmaz D, Pileri P, Abrignani S (1994) Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 180:1159-1164.
20. Hoofnagle JH, Di Bisceglie AM (1997) The treatment of chronic viral hepatitis. N Engl J Med 336:347-356.
21. Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y (1993) A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105:507-512.
22. Castro A, Carballo E, Domínguez A, Diago M, Suárez D, Quiroga JA, Carreño V (1997) Tolerance and efficacy of subcutaneous interferon-beta administered for treatment of chronic hepatitis C. J Interferon Cytokine Res 17:65-67.
23. Pardo M, Castillo I, Navas S, Carreño V (1995) Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha. J Med Virol 45:439-444.
24. Carreño V, Parra A, Navas S, Quiroga JA (1996) Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for interferon-α treatment of chronic hepatitis C. Cytokine 8:318-322.
25. Pardo M, Castillo I, Oliva H, Fernández-Flores A, Bárcena R, Antje de Peuter M, Carreño V (1997) A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C. Hepatology 26:1318-1321.
26. Martín J, Navas S, Quiroga JA, Carreño V (1996) Recombinant human granulocyte colony-stimulating factor reduces hepatitis C virus replication in mononuclear cells from chronic hepatitis C patients. Cytokine 8:313-317.
27. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC (1997) Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity. Hepatology 25:449-458.
28. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, Houghton M, Walker BD (1995) HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96:2311-2321.
29. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G, Ferrari C (1997) Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193-199.
30. Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM (1995) Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood. Cytokine 7:815-822.
31. Balmer CM (1991) Clinical use of biologic response modifiers in cancer treatment: An overview. Part I. The interferons. Drug Intell Clin Pharm 24:761-768.
32. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:99-106.
33. Davey RT Jr, Chaitt DG, Piscitelli SC, Wells M, Kovacs JA, Walker RE, Falloon J, Polis MA, Metcalf JA, Masur H, Fyfe G, Lane HC (1997) Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons. J Infect Dis 175:781-789.
34. Martín J, Navas S, Quiroga JA, Pardo M, Carreño V (1998) Effects of the ribavirin-interferon α combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine 10:635-644.
35. Aman MJ, Tretter T, Eisenbeis I, Bug G, Decker T, Aulitzky WE, Tilg H, Huber C, Peschel C (1996) Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 87:4731-4736.
36. Platanias LC, Uddin S, Colamonici OR (1994) Tyrosine phosphorylation of the α and β subunits of the type I interferon receptor. J Biol Chem 269:17761-17764.
37. Tilg H (1997) New insights into the mechanism of interferon alfa: An immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112:1017-1021.
38. Ruíz-Moreno M, Fernández P, Leal A, Bartolomé J, Castillo I, Oliva H, Carreno V (1997) Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy. Pediatrics 99:222-225.
39. Brotons A, Quiroga JA, Martín J, Anchía P, Pardo M, Carreno V (1997) Daily subcutaneous administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the treatment of chronic hepatitis C [Abstract]. J Hepatol 26 (Suppl. 1):83.
40. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY (1997) The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 158:1473-1481.
41. Vella AT, Mitchell T, Groth B, Linsley PS, Green JM, Thompson CB, Kappler JW, Marrack P (1997) CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J Immunol 158:4714-4720.
42. Desmet VJ, Gerber MA, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520.
43. Madejón A, Fogeda M, Bartolomé J, Pardo M, González C, Cotonat T, Carreño V (1997) GB virus C RNA in serum, liver and peripheral blood mononuclear cells from patients with chronic hepatitis B, C and D. Gastroenterology 113:573-578.
44. Pernas M, Bartolomé J, Castillo I, Quiroga JA, Pardo M, Carreno V (1995) Sequence of nonstructural regions 3 and 5 of hepatitis C virus genomes from spanish patients: Existence of a predominant variant related to type 1b. J Gen Virol 76:415-120.
45. Navas S, Castillo I, Martín J, Quiroga JA, Bartolomé J, Carreno V (1997) Concordance of hepatitis C virus typing methods based on RFLP analysis in 5′ non-coding region, and NS4 serotyping, but not in core-PCR or a line probe assay. J Clin Microbiol 35:317-321.
46. Balmer CM (1991) Clinical use of biologic response modifiers in cancer treatment: An overview. Part II. Colony-stimulating factors and interleukin-2. Drug Intell Clin Pharm 25:490-498.
47. Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K (1994) Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J Hepatol 21:527-535. {12580427}